Literature DB >> 10336173

Diversity of mRNA expression for muscarinic acetylcholine receptor subtypes and neuronal nicotinic acetylcholine receptor subunits in human mononuclear leukocytes and leukemic cell lines.

K Z Sato1, T Fujii, Y Watanabe, S Yamada, T Ando, F Kazuko, K Kawashima.   

Abstract

Previously, we reported that various levels of acetylcholine (ACh), currently known as a neurotransmitter, are detectable in the blood of several mammals including humans and that most blood ACh originates from T-lymphocytes. To investigate whether ACh in the blood acts on lymphocytes and participates in the modulation of immune responses, we have analyzed the expression of mRNA for muscarinic (Ms) ACh receptor subtypes and nicotinic (Nc) ACh receptor subunits using reverse transcription-polymerase chain reaction (RT-PCR) methods. The cells tested were human peripheral mononuclear leukocytes (MNLs) from seven healthy donors and eight leukemic cell lines, as models of lymphocytes. We detected mRNA expression for various neuronal Nc receptor subunits and Ms receptor subtypes in all of the MNL samples and in all of the cell lines tested. However, the expression pattern of mRNA for neuronal Nc receptor subunits (alpha2-alpha7 and beta2-beta4) and Ms receptor subtypes (m1-m5) varied among the individuals and cell lines. No expression of mRNA for three muscle-type Nc receptor subunits (alpha1, beta1 and epsilon) was observed in the MNLs and cell lines. These results indicate that both neuronal-type Nc and Ms ACh receptors are present on the surface of lymphocytes.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10336173     DOI: 10.1016/s0304-3940(99)00259-1

Source DB:  PubMed          Journal:  Neurosci Lett        ISSN: 0304-3940            Impact factor:   3.046


  51 in total

1.  Upregulation of mRNA encoding the M5 muscarinic acetylcholine receptor in human T- and B-lymphocytes during immunological responses.

Authors:  Takeshi Fujii; Yoshihiro Watanabe; Tomoyuki Inoue; Koichiro Kawashima
Journal:  Neurochem Res       Date:  2003-04       Impact factor: 3.996

Review 2.  The cholinergic anti-inflammatory pathway: a missing link in neuroimmunomodulation.

Authors:  Valentin A Pavlov; Hong Wang; Christopher J Czura; Steven G Friedman; Kevin J Tracey
Journal:  Mol Med       Date:  2003 May-Aug       Impact factor: 6.354

3.  Nicotinic acetylcholine receptor expression on B-lymphoblasts of healthy versus schizophrenic subjects stratified for smoking: [3H]-nicotine binding is decreased in schizophrenia and correlates with negative symptoms.

Authors:  Christian Luckhaus; Uwe Henning; Stefano Ferrea; Francesco Musso; Arian Mobascher; Georg Winterer
Journal:  J Neural Transm (Vienna)       Date:  2011-12-11       Impact factor: 3.575

4.  Analysis of CD8+ T cell-mediated anti-viral responses in mice with targeted deletions of the M1 or M5 muscarinic cholinergic receptors.

Authors:  Vaiva Vezys; David Masopust; Maxime Desmarets; Jürgen Wess; James C Zimring
Journal:  Life Sci       Date:  2007-01-13       Impact factor: 5.037

5.  Role of muscarinic receptors in the regulation of immune and inflammatory responses.

Authors:  Seddigheh Razani-Boroujerdi; Muskaan Behl; Fletcher F Hahn; Juan Carlos Pena-Philippides; Julie Hutt; Mohan L Sopori
Journal:  J Neuroimmunol       Date:  2008-01-10       Impact factor: 3.478

6.  CHRFAM7A gene expression in schizophrenia: clinical correlates and the effect of antipsychotic treatment.

Authors:  Sunil V Kalmady; Rimjhim Agrawal; Deepthi Venugopal; Venkataram Shivakumar; Anekal C Amaresha; Sri Mahavir Agarwal; Manjula Subbanna; Ashwini Rajasekaran; Janardhanan C Narayanaswamy; Monojit Debnath; Ganesan Venkatasubramanian
Journal:  J Neural Transm (Vienna)       Date:  2018-01-05       Impact factor: 3.575

Review 7.  Autonomic regulation of T-lymphocytes: Implications in cardiovascular disease.

Authors:  Safwan K Elkhatib; Adam J Case
Journal:  Pharmacol Res       Date:  2019-06-06       Impact factor: 7.658

Review 8.  Cholinergic modulation of the immune system presents new approaches for treating inflammation.

Authors:  Donald B Hoover
Journal:  Pharmacol Ther       Date:  2017-05-18       Impact factor: 12.310

Review 9.  Neuroimmune Communication in Health and Disease.

Authors:  Colin Reardon; Kaitlin Murray; Alan E Lomax
Journal:  Physiol Rev       Date:  2018-10-01       Impact factor: 37.312

10.  Nicotinic acetylcholine receptor expression and susceptibility to cholinergic immunomodulation in human monocytes of smoking individuals.

Authors:  Esmerij P van der Zanden; Francisca W Hilbers; Caroline Verseijden; Rene M van den Wijngaard; Mike Skynner; Kevin Lee; Luis Ulloa; Guy E Boeckxstaens; Wouter J de Jonge
Journal:  Neuroimmunomodulation       Date:  2012-03-21       Impact factor: 2.492

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.